SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001567619-22-018298
Filing Date
2022-10-06
Accepted
2022-10-06 10:23:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G 64622
  Complete submission text file 0001567619-22-018298.txt   65946
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Subject) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89384 | Film No.: 221297330
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1200 BRICKELL AVENUE, #1470 MIAMI FL 33131
Business Address
STONE DANIEL E. (Filed by) CIK: 0001948744 (see all company filings)

Type: SC 13G